Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
18
Sort by:
Global Adjuvanted Influenza Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Adjuvanted Influenza Vaccine market size is predicted to grow from US$ 1316 million in 2025 to US$ 2978 million in 2032; it is expected to grow at a CAGR of 12.6% from 2026 to 2032. An adju...
September 2026
84 pages
Global Egg-Based Flu Vaccines Market Growth 2026-2032
US$ 3,660.00
The global Egg-Based Flu Vaccines market size is predicted to grow from US$ 8282 million in 2025 to US$ 11720 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032. The most comm...
September 2026
114 pages
Global Egg-free Flu Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Egg-free Flu Vaccine market size is predicted to grow from US$ 906 million in 2025 to US$ 1808 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032. An Egg-free Flu...
September 2026
84 pages
Global Multiple Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Multiple Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The process of upgrading global mu...
September 2026
102 pages
Global Recombinant Influenza Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Recombinant Influenza Vaccine market size is predicted to grow from US$ 131 million in 2025 to US$ 234 million in 2032; it is expected to grow at a CAGR of 8.8% from 2026 to 2032. Recombina...
September 2026
84 pages
Philippines Vaccine Market Size, Share, Trends and Forecast by Technology, Patient Type, Indication, Route Of Administration, Product Type, Treatment Type, End User, Distribution Channel, and Region, 2026-2034
US$ 2,999.00
The Philippines vaccine market size reached USD 294.8 Million in 2025. Looking forward, the market is projected to reach USD 621.3 Million by 2034, exhibiting a growth rate (CAGR) of 8.38% during 2026...
July 2026
121 pages
Turkey Vaccine Market Size, Share, Trends and Forecast by Technology, Patient Type, Indication, Route of Administration, Product Type, Treatment Type, End User, Distribution Channel, and Region, 2026-2034
US$ 2,999.00
The Turkey vaccine market size reached USD 847.9 Million in 2025. The market is projected to reach USD 1,788.3 Million by 2034, exhibiting a growth rate (CAGR) of 8.39% during 2026-2034. The market is...
July 2026
118 pages
Africa Vaccine Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others) and Forecast 2026–2035
US$ 3,840.00
Africa Vaccine Market was valued at USD $250 million in 2026 and is projected to reach USD $690 million by 2035, registering a CAGR of 12.0% across the forecast period. The Africa Vaccine Market conti...
April 2026
445 pages
